SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001567619-22-003831
Filing Date
2022-02-14
Accepted
2022-02-14 09:24:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 64840
  Complete submission text file 0001567619-22-003831.txt   66636
Mailing Address 25 EAST ERIE ST CHICAGO IL 60611
Business Address 25 EAST ERIE ST CHICAGO IL 60611 3125873800
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000938206 (see all company filings)

IRS No.: 203634295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92879 | Film No.: 22626157
SIC: 2834 Pharmaceutical Preparations